In the orchestra of aging, every instrument has its own part, and the conductor doesn't always wave the baton the same way. The protein SIRT6 was long considered the master regulator of longevity: with plenty of it, a cell lives longer; with too little, it wears out faster. But when researchers pooled data from 1648 scientific papers and compared gene activity in humans, mice, rats, macaques, pigs, and fruit flies, the picture turned out to be more complicated. SIRT6 doesn't play the same tune in every organism.

Remove SIRT6, and the cell starts to breathe poorly. It's like an orchestra where all the woodwinds suddenly stop playing: the music still sounds, but it loses its depth. And yet only two genes out of thousands changed the same way in every species studied: ZNF518A became more active, while BZW1 became quieter. All other responses depended on the tissue, the sex, and even on whether the subject was a mouse or a human.

In Alzheimer's disease, SIRT6 behaves like a conductor who plays different music in different halls. In neurons, the brain's main cells, its levels fall already in the early stages of the disease. In microglia, the brain's immune cells, they rise instead. And in astrocytes, the support cells, they decline only in the late stages. The same protein in one organ can both protect and harm, depending on which cell it's working in.

It used to seem that measuring SIRT6 levels could tell you exactly how old a person was. Now it's clear: this protein is not a universal marker but rather an indicator of local problems. Aging researchers will have to take into account which tissue and which species they are looking at SIRT6 in, otherwise their conclusions will resemble an attempt to judge the whole orchestra by a single violinist.

Take the whole work

Not published on arXiv. Here are its page, the PDF and the formalization: you can check it yourself, not only read our account.

the paper's page